购物车
- 全部删除
- 您的购物车当前为空
5-LOX/sEH-IN-1(Compound 8o)作为一种双重5-LOX/sEH抑制剂,展示了显著的心脏保护特性,其IC50值分别达到3.05 μM和2.20 nM.此外,该化合物还能抑制COX-2活性(IC50=10.50 μM).5-LOX/sEH-IN-1不仅具有镇痛和抗炎效果,还能降低溃疡的发病率,有望开发成具有较少胃肠道和心血管副作用的抗炎药物.
5-LOX/sEH-IN-1(Compound 8o)作为一种双重5-LOX/sEH抑制剂,展示了显著的心脏保护特性,其IC50值分别达到3.05 μM和2.20 nM.此外,该化合物还能抑制COX-2活性(IC50=10.50 μM).5-LOX/sEH-IN-1不仅具有镇痛和抗炎效果,还能降低溃疡的发病率,有望开发成具有较少胃肠道和心血管副作用的抗炎药物.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Compound 8o (5-LOX/sEH-IN-1) is a dual inhibitor with cardioprotective properties, targeting both 5-LOX and sEH with IC50 values of 3.05 μM and 2.20 nM respectively. It also inhibits the activity of COX-2 (IC50=10.50 μM). Possessing analgesic and anti-inflammatory properties, 5-LOX/sEH-IN-1 reduces ulcerogenicity, making it a potential candidate for developing anti-inflammatory agents with fewer gastrointestinal and cardiovascular side effects. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.